|
Executive Sponsor
|
|
Adding Value to Your Drug Development Journey. Avecia Oligomedicines is a world leading Contract Manufacturing Organization solely focused on the development and manufacture of oligonucleotides for therapeutic applications. Avecia has manufactured over 1000 sequences and has expertise in DNA, RNA, siRNA, Aptamers, Chimeras and Molecular Decoys. Our FDA-registered facility, located in Milford, MA manufactures oligonucleoticde Active Pharmaceutical Ingredients (API) and Intermediates meeting the international requirements of ICH Q7A. The most recent FDA Inspection of our Milford facility in April 2005, raised NO observations or points of discussion, thus signifying our compliance with all appropriate standards and regulations. Avecia has development and manufacturing capability for Pre-clinical ,Clinical and Commercial Product markets. Our aim is to leverage our wealth of experience, and our understanding of the regulatory needs in each of these market segments, to ensure we exceed our customers expectations. Our mission is to build value for our customers as they progress along the drug development journey.
|
|
|
Corporate Sponsors
|
|
As the market for Oligonucleotides continues to grow, ChemGenes remains committed to introducing novel products, while maintaining our existing product mix. With over 25 years of experience in phosphoramidite chemistry, our custom synthesis capabilities are unmatched. Moreover, our recent relocation has tripled our capacity and has allowed us to bulk manufacture to the industry norm. Our existing line of products includes a wide array of modifications for oligonucleotide synthesis - available globally. All of us at ChemGenes are devoted to providing you with invaluable customer service and comprehensive technical assistance.
|
|
Girindus, a member of Solvay Organics, is a leading manufacturer of cGMP Oligonucleotides and is unique in offering both, solid and solution phase manufacturing technologies. Girindus operates both technologies at FDA inspected plants in Germany (Kuensebeck) and in the US (Cincinnati, Ohio) which support API supplies from clinical trial phases into market. The solid phase production in the US is currently being significantly expanded. This multi-million dollar expansion will allow for simultaneous production of multiple commercial oligonucleotides and be operational in 2008. Visit www.girindus.com or contact us: oligo@girindus.com
|
|
PolyPeptide Laboratories Group is a leading provider of custom/generic GMP-grade peptides for a range of pharmaceutical applications. With corporate roots that began in the 1950s, the group was formally launched in 1996. After acquiring peptide manufacturer NeoMPS in November 2007, the Group now has 6 GMP facilities (one still in development) located across 3 continents. Its world-class chemists and support personnel offer an unparalleled range of services for clients of every size and at every stage of product development.
|
|
|
Associate Sponsors
|
|
Agilent, through its Nucleic Acid Solutions Division based in Boulder, Colo. USA, is a leading manufacturer of next-generation oligo therapeutics. Operating out of a state-of-the-art, multi-product facility, the division offers flexible cGMP oligo production at scales from grams to kilograms. Agilent also offers a full range of turn-key development services, including development of analytical methods and processes, stability studies, quality control, and regulatory support.
|
|
Eurogentec is a global provider of innovative products and services to the Research, Diagnostic and Pharmaceutical communities: oligonucleotides, antibodies, proteins, plasmids, peptides, arrays, and Real-Time qPCR kits. Multi-site oligo manufacturing capabilities in Europe, USA, Japan and Singapore ensures IVD customers an uninterrupted supply of high quality R&D and GMP assay components
|
|
MedTRACK is the most comprehensive database of over 11,100 global private and public biomedical companies. Business development and financial professionals use MedTRACK to obtain competitive and strategic analysis data on pipeline, partnering and venture information on biomedical companies and products worldwide. MedTRACK also has two companion products, Venture Finance and MedTRACK Japan. www.medtrack.com
|
|
NOF offers innovative excipients in pharmaceuticals such as activated PEGs for drug modifiers, high-purity phospholipids, ultra-pure oleic acid, ultra-pure polysorbate 80, ultra-pure PEG 200, 300 and 400, noble solubilizers, high-purity chitosan. As a worldwide leader in drug delivery systems, NOF provides these excellent quality products for commercial supply under cGMP.
|
|
Thermo Scientific represents Thermo Fisher Scientific's broad range of high-end analytical instruments, chemistry and consumable supplies, laboratory equipment, software and services that enable integrated laboratory workflow solutions. We provide innovative products and services for synthesis, detection, modification and labeling of nucleic acids to researchers, molecular diagnostics, and therapeutic companies.
|
|
